z-logo
open-access-imgOpen Access
Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing
Author(s) -
Belinda McClaren,
MaryAnne Aitken,
John Massie,
David J. Amor,
Obioha C. Ukoumunne,
Sylvia A. Metcalfe
Publication year - 2013
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2012.175
Subject(s) - genetic testing , carrier testing , curiosity , relevance (law) , medicine , newborn screening , test (biology) , genetic counseling , family medicine , psychology , developmental psychology , clinical psychology , pediatrics , social psychology , genetics , pregnancy , prenatal diagnosis , fetus , paleontology , biology , political science , law
Newborn screening for cystic fibrosis is increasingly available, but cascade testing following the diagnosis in a child has received little attention. We previously reported low levels of cascade testing over time, and this study investigated motivators as well as barriers to testing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom